entity

Mitochondrial dynamics / bioenergetics

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Mitochondrial dynamics / bioenergetics: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

12Connections
11Hypotheses
5Analyses
0Outgoing
12Incoming
20Experiments
6Debates

No AI portrait yet

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (12)

SourceRelationTypeStr
CGASparticipates_ingene0.54
STING1participates_ingene0.54
DNASE2participates_ingene0.54
COX4I1participates_ingene0.47
TFAMparticipates_ingene0.46

Targeting Hypotheses (11)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Senescent Cell Mitochondrial DNA Release 0.742 neurodegeneration Senolytic therapy for age-related neurod
Near-infrared light therapy stimulates COX4-dependent mitoch 0.742 neurodegeneration Mitochondrial transfer between astrocyte
TFAM overexpression creates mitochondrial donor-recipient gr 0.725 neurodegeneration Mitochondrial transfer between astrocyte
Mitochondrial Transfer Pathway Enhancement 0.695 neurodegeneration Astrocyte reactivity subtypes in neurode
CX43 hemichannel engineering enables size-selective mitochon 0.686 neurodegeneration Mitochondrial transfer between astrocyte
CRISPR-Mediated Mitochondrial Genome Editing for Complex I D 0.681 neurodegeneration CRISPR-based therapeutic approaches for
RAB27A-dependent extracellular vesicle engineering for mitoc 0.674 neurodegeneration Mitochondrial transfer between astrocyte
GAP43-mediated tunneling nanotube stabilization enhances neu 0.666 neurodegeneration Mitochondrial transfer between astrocyte
Mitochondrial RNA Granule Rescue Pathway 0.656 neurodegeneration RNA binding protein dysregulation across
Mitochondrial SPM Synthesis Platform Engineering 0.647 neurodegeneration Neuroinflammation resolution mechanisms
Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m 0.621 neurodegeneration Mitochondrial transfer between astrocyte

Mentioning Analyses (5)

Scientific analyses that reference this entity

Mitochondrial transfer between astrocytes and neurons

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.813

RNA binding protein dysregulation across ALS FTD and AD

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.720

Neuroinflammation resolution mechanisms and pro-resolving mediators

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.784

Senolytic therapy for age-related neurodegeneration

neurodegeneration | 2026-04-01 | 8 hypotheses Top: 0.910

Astrocyte reactivity subtypes in neurodegeneration

neurodegeneration | 2026-04-01 | 7 hypotheses Top: 0.741

Experiments (20)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
IRI-AKI mouse model with mtROS inhibition validation ischemic acute kidney injury 0.900 0.00 IRI-AKI mice proposed N/A
mtROS effects on TFAM and mtDNA in HK2 cells exploratory acute kidney injury 0.900 0.00 HK2 cells proposed N/A
Cx43 knockdown effects on mitochondrial transfer exploratory osteoarthritis 0.900 0.00 human bone marrow-derived MSCs proposed N/A
TFAM knockdown functional analysis exploratory acute kidney injury 0.850 0.00 HK2 cells proposed N/A
Confocal imaging of MSC-chondrocyte interactions during mitochondrial exploratory osteoarthritis 0.850 0.00 human bone marrow-derived MSCs proposed N/A
TFAM and mtDNA analysis in AKI patients clinical acute kidney injury 0.800 0.00 human patients proposed N/A
Rab27a knockdown effects on microglia activation in developing brain validation 0.800 0.00 Neonatal mice with dorsal subv proposed N/A
Proposed experiment from debate on Senolytics targeting p16/p21+ senes falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Biomechanical Impact Profiles and Chronic Traumatic Encephalopathy Phe clinical Neurodegeneration 0.400 0.50 in_silico proposed $180,000
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk Cohorts clinical ALS 0.400 0.50 human proposed $6,550,000
cGAS-STING Pathway Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $7,100,000
Mixed Pathology Effects on Parkinson's Disease Progression and Treatme clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
NLRP3 Inflammasome Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $5,460,000
Regulated Necrosis Validation Study in Parkinson's Disease clinical Parkinson's Disease 0.400 0.50 human proposed $6,550,000
Senolytic Therapy (D+Q) Phase IIa Trial in Early Alzheimer's Disease clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
Traumatic Brain Injury and Alzheimer's Disease Relationship validation Alzheimer's Disease 0.400 0.50 human proposed $3,000,000
Viral Infections and Alzheimer's Disease — causal mechanisms and thera clinical Alzheimer's Disease 0.400 0.50 human proposed $5,460,000
s:** - Test MCU overexpression specifically in layer II neurons in hea falsification Neurodegeneration 0.400 0.50 mouse proposed $200,000
Proposed experiment from debate on Mitochondrial transfer between astr falsification Neurodegeneration 0.400 0.50 cell_line proposed $80,000
Mechanism: Selective Vulnerability of Dopaminergic Neurons in Parkinso validation Parkinson's Disease 0.400 0.50 human proposed $3,000,000

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Organelle-specific autophagy in inflammatory diseases: a potential therapeutic t [PMID:32048886] Yao RQ, Ren C, Xia ZF, Yao YM Autophagy 2021 2
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 2
Allosteric properties of mammalian ALOX15 orthologs. [PMID:41654134] Yang J, Borchert A, Kuhn H J Biol Chem 2026 1
Astrocytic Connexin43 in Alzheimer's disease: mechanisms, interaction with P2 re [PMID:41062060] Xiong W, Su Y, Verkhratsky A, Yi C Neuropharmacology 2026 1
Miro1: A potential target for treating neurological disorders. [PMID:40403957] Zeng L, Yang J, Zhang C, Zhu J, Zhong S, Neuroscience 2025 1
Connexin43 hemichannel blockade turns microglia neuroprotective and mitigates co [PMID:40595567] Su Y, Li H, Zhang W, Tao S, Wang Q, Zhan Nat Commun 2025 1
Imp/IGF2BP and Syp/SYNCRIP temporal RNA interactomes uncover combinatorial netwo [PMID:39919181] Lee JY, Huang N, Samuels TJ, Davis I Sci Adv 2025 1
Calcium-Associated Proteins in Neuroregeneration. [PMID:38397420] Lisek M, Tomczak J, Boczek T, Zylinska L Biomolecules 2024 1
Melatonin attenuates sepsis-induced acute kidney injury by promoting mitophagy t [PMID:37651673] Deng Z, He M, Hu H, Zhang W, Zhang Y, Ge Autophagy 2024 1
TFAM is an autophagy receptor that limits inflammation by binding to cytoplasmic [PMID:38783142] Liu H, Zhen C, Xie J, Luo Z, Zeng L, Zha Nat Cell Biol 2024 1
SBFI26 induces triple-negative breast cancer cells ferroptosis via lipid peroxid [PMID:38516826] He G, Zhang Y, Feng Y, Chen T, Liu M, Ze J Cell Mol Med 2024 1
Should it stay or should it go: gap junction protein GJA1/Cx43 conveys damaged l [PMID:39394955] Domingues N, Ribeiro-Rodrigues T, Girão Autophagy 2024 1
Connexin 43 regulates intercellular mitochondrial transfer from human mesenchyma [PMID:39390589] Irwin RM, Thomas MA, Fahey MJ, Mayán MD, Stem Cell Res Ther 2024 1
Mitochondria from osteolineage cells regulate myeloid cell-mediated bone resorpt [PMID:38877020] Ding P, Gao C, Zhou J, Mei J, Li G, Liu Nat Commun 2024 1
Increased mitophagy protects cochlear hair cells from aminoglycoside-induced dam [PMID:35471096] Zhang Y, Fang Q, Wang H, Qi J, Sun S, Li Autophagy 2023 1
RNA binding protein SYNCRIP maintains proteostasis and self-renewal of hematopoi [PMID:37085479] Herrejon Chavez F, Luo H, Cifani P, Pine Nat Commun 2023 1
Tumour extracellular vesicles and particles induce liver metabolic dysfunction. [PMID:37225988] Wang G, Li J, Bojmar L, Chen H, Li Z, To Nature 2023 1
Selective inhibition of cannabinoid CB(1) receptor-evoked signalling by the inte [PMID:37689260] Maroto IB, Moreno E, Costas-Insua C, Mer Neuropharmacology 2023 1
Extracellular vesicles in fatty liver promote a metastatic tumor microenvironmen [PMID:37172577] Wang Z, Kim SY, Tu W, Kim J, Xu A, Yang Cell Metab 2023 1
Mitochondrial-derived damage-associated molecular patterns amplify neuroinflamma [PMID:35233090] Lin MM, Liu N, Qin ZH, Wang Y Acta Pharmacol Sin 2022 1

Debates (6)

Multi-agent debates referencing this entity

RNA binding protein dysregulation across ALS FTD and AD

closed · Rounds: 4 · Score: 0.72 · 2026-04-12

Astrocyte reactivity subtypes in neurodegeneration

closed · Rounds: 4 · Score: 0.95 · 2026-04-10

Senolytics targeting p16/p21+ senescent astrocytes and microglia may reduce SASP

closed · Rounds: 4 · Score: 0.89 · 2026-04-06

SPMs (resolvins, protectins, maresins) from omega-3s may promote inflammation re

closed · Rounds: 4 · Score: 0.83 · 2026-04-06

RNA binding protein dysregulation across ALS FTD and AD

closed · Rounds: 4 · Score: 0.88 · 2026-04-06

Mitochondrial transfer between astrocytes and neurons

closed · Rounds: 4 · Score: 0.95 · 2026-04-06